Next Article in Journal
Molecular Mechanisms of Lymph Node Metastasis in Gallbladder Cancer: Insights into the Tumor Microenvironment
Previous Article in Journal
Soluble CD146 in Heart Failure: Pathophysiological Role and Diagnostic Potential
Previous Article in Special Issue
Intracellular Iron Deficiency and Abnormal Metabolism, Not Ferroptosis, Contributes to Homocysteine-Induced Vascular Endothelial Cell Death
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Deoxygenation Trends and Their Multivariate Association with Self-Reported Fatigue in Post-COVID Syndrome

1
Department of Ophthalmology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Germany
2
PhD Medical Sciences, Department of Human Medicine, Paracelsus Medical University, 5020 Salzburg, Austria
3
Research Unit Analytical BioGeoChemistry, Helmholtz Zentrum München, 85764 Neuherberg, Germany
4
Rotkreuzklinik Lindenberg, 88161 Lindenberg, Germany
5
Department of Internal Medicine 1, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Germany
6
Department of Internal Medicine 3—Rheumatology and Immunology, Deutsches Zentrum Immuntherapie and Center for Rare Diseases Erlangen, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Germany
*
Authors to whom correspondence should be addressed.
Biomedicines 2025, 13(6), 1371; https://doi.org/10.3390/biomedicines13061371
Submission received: 30 April 2025 / Revised: 23 May 2025 / Accepted: 28 May 2025 / Published: 3 June 2025

Abstract

:
Background/Objectives: A relevant subgroup of post-COVID-19 syndrome (PCS) patients suffers from post-exertional malaise (PEM) and cardiovascular or neurological symptoms, impairing daily functioning up to becoming even house- or bedbound. Recent data suggest that PCS summarizes different subgroups, one of them being characterized by an impaired microcirculation. Thus, the aim of the present study was to investigate local deoxygenation, measured with non-invasive near-infrared regional spectroscopy (NIRS), and its association with self-reported fatigue in patients with PCS compared to controls in light exercise. Methods: 150 participants (100 PCS patients and 50 controls) were recruited. PEM was assessed using FACIT, Chalder, and Bell scoring and Canadian Criteria. NIRS was used to measure local oxygenation while kneading a stress ball and during recovery. Results: PCS patients showed fatigue scores of 30 (Bell score), 20.6 (FACIT fatigue score), and 9.914 (Chalder fatigue score). Decreased deoxygenation peaks at the start of exercise were observed in patients with PCS, compared to controls (p = 0.0002). Multivariate analysis identified a subgroup, showing an association between strong fatigue and restricted oxygenation dynamics. Conclusions: NIRS could be a potential tool to assess deoxygenation deficits even in moderate to severely impaired PCS patients using light exercise protocols.

1. Introduction

Approximately 6% of patients with acute COVID-19 have persisting post-acute sequelae for at least 12 weeks after acute infection, thus suffering from long COVID (LC)/post-COVID-19-syndrome (PCS) according to the WHO [1,2]. The prevalence varies depending on cohorts and vaccination status. More than 200 symptoms characterize PCS; the most frequently reported are fatigue, brain fog, post-exertional malaise (PEM), cardiovascular symptoms, and neurological conditions, including cognitive dysfunction and sleep and sensorimotor disturbances [1,3,4,5]. Among PCS patients, those who are classified as medium-severe to severely affected are largely wheelchair and housebound. Their main symptom, PEM, restricts their daily life by experiencing symptoms at rest with exertion-triggered exacerbations of symptoms, often after a time lag. The diversity of PCS symptoms is likely triggered by different molecular mechanisms, arguing for different PCS subtypes [6,7,8,9,10]. It is assumed that immune and autoimmune dysregulation (e.g., functional autoantibodies targeting G-protein coupled receptors) [11], persisting viral reservoirs or viral reactivation [12], abnormal blood clotting [10], and endothelial dysfunctions act independently or interact in the complex pathogenesis of PCS.
A subgroup of patients with PCS shows a restricted capillary microcirculation, linked to chronic fatigue (CF) [13]. It can be assumed that restricted capillary perfusion can be induced or even induce endothelial dysfunction and impaired oxygenation (reviewed in [14]), further limiting perfusion and mitochondrial function (reviewed in [15]). In addition, these patients’ group yielded functional autoantibodies, targeting G-protein coupled receptors (GPCR-fAAb) associated with the restricted microcirculation [16]. Of interest, the neutralization of GPCR-fAAb by BC007 (Berlin Cures GmbH, Berlin, Germany) was accompanied by an improvement in capillary microcirculation and PCS symptoms [17]. The data of a phase IIa study with BC007 in patients with PCS confirmed the improvement of PCS symptoms after the neutralization of GPCR-fAAb [18].
Regional oxygenation and changes in hemoglobin (Hb) or myoglobin (Mb) oxygenation are of interest, considering restricted capillary microcirculation. This can be measured with near-infrared spectroscopy (NIRS), which is available in portable, relatively cost-effective devices and widely used clinically in intensive care and anaesthesiology and research on exercise physiology [19,20]. As only the muscle beneath the sensor is measured, full-body exercise is not required for analysis. Therefore, it could be a safer, readily available option to investigate oxygenation abnormalities in PCS compared to cardiopulmonary exercise testing (reviewed in [21]), avoiding triggering PEM.
The study aimed to investigate muscle (de)oxygenation during light and local exercise, assessed using NIRS, in patients with PCS compared to controls. In addition, a multivariate analysis was performed to explore the relationship between NIRS-derived oxygenation metrics and self-reported fatigue.

2. Materials and Methods

2.1. Patients

A total of 150 participants were recruited at the Department of Ophthalmology, Universitätsklinikum Erlangen, Friedrich Alexander University of Erlangen-Nürnberg as part of the disCOVer 2.0 study: 100 patients with PCS (55 female, 45 male) and 50 controls (27 female, 23 male). Demographic data, including age, sex, positive PCR report, relevant medical history, and PCS symptom duration, were collected from all patients. Inclusion criteria for patients with PCS were persistent post-acute sequelae of COVID-19 for at least 3 months after a polymerase chain reaction (PCR)-verified COVID-19 infection. On the day of the investigation, participants were asked to self-report on four different questionnaires targeting fatigue. Fulfillment of the Canadian Criteria for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), a questionnaire facilitating the diagnostics of ME/CFS according to the international consensus criteria [22]. The Chalder fatigue scale, an 11-item questionnaire assessing physical and psychological fatigue with high reliability in ME/CFS studies and occupational research, a high score expresses high fatigue [23]. The Bell score, which has also been developed to judge the severity of chronic fatigue syndrome, the activity that can be performed, and the frequency of symptoms [24]. The Bell score is counter-proportional to fatigue, with healthy people scoring a maximum of 100. Lastly, the FACIT fatigue score asks the patient to judge how applicable certain statements are regarding their fatigue symptoms during the past 7 days. It also targets physical- and psychological fatigue and scores counter proportionally to fatigue [25].
Several steps were taken to reduce known confounders: Baum [26] and colleagues found that the severity of fatigue in most cases did not correlate with cardiovascular diseases or echocardiographic findings, except in patients with significant functional impairments. Additionally, the study by Thiele et al. [27] showed that fatigue was the most common symptom 6 months after COVID-19, but it did not correlate with the variables of lung function tests (LFT) or left ventricular ejection fraction (LVEF). Lung abnormalities as well as cardiological issues have already been excluded in previous studies initiated by the respective general practitioners, as well as pulmonologists and cardiologists. This has ultimately led to these patients being referred to a POST-COVID center for further clarification, as these findings were considered unremarkable. Moreover, these were reviewed by a physician of the study team and those with any pathologic findings (e.g., oxygen diffusion impairment, restrictive or obstructive lung function aberrations or heart valve prolapse or insufficiency, abnormal contractility or abnormal ejection fractions) were excluded. All PCS patients were also seen by a licensed internal medicine physician during the study and their previous medical history was reviewed; those with a potential organic cause of medium to severe fatigue other than PCS due to other immune diseases, tumors or organ diseases like overt primary heart, lung, liver, thyroid or kidney disease were excluded.
Although measures were taken to exclude possible confounders, the origin of fatigue for PCS on an individual basis is unknown and could include many causes, including neurological, autonomic, muscular, cardiovascular, hematologic, or mitochondrial alterations [8,9,15]. This causes the PCS group to be likely heterogeneous in its cause of fatigue, potentially obscuring the result and may account for the high variance. All participants signed a written informed consent form, which included giving permission to submit the anonymized clinical data in a scientific publication, in agreement with the Declaration of Helsinki and with permission from the ethics commission (no: 295-20-B).

2.2. NIRS

The Masimo O3® regional oximeter with Delta cHbi (Masimo Corporation, Irvine, CA, USA) was used to measure regional muscle oxygenation of the underarm flexors. The device uses near-infrared spectroscopy (NIRS) based on diffuse continuous wave multidistance reflection spectroscopy. The sensors have one emitter and two detectors (i.e., one shallow detector and one deep detector), which allows for the selective calculation of oxygenation in deep tissues by excluding the effects of the superficial tissue. The parameters are calculated based on the different absorption coefficients on the basis of the Lambert–Beer law. Recorded values are changes from the baseline of oxygenated Hb and Mb (delta O2Hbi; scale: 1 µM from −98.0 to 99.0), deoxygenated Hb and Mb (delta HHbi; scale: 1 µM from −98.0 to 99.0) and total change in Hb and Mb (delta cHbi; scale: 1 µM from −98.0 to 99.0) as well as regional oxygenation (rSO2; scale: % change).
While the absorption coefficients of Hb and Mb are too similar to be distinguishable in NIRS, it is generally assumed that the change in oxygenation and deoxygenation as well as total change resulting from Hb changes, since Mb is located inside the muscle and does not change concentrations [19,20,28].
Patients were seated at rest for at least 5 min before starting the investigation. The self-adhering sensor was applied over the underarm flexors. The sensor application spot was shaved in those with thick or dark hair. The sensor was additionally secured and shielded from light with a dark bandage. The measurement baseline was established according to the manufacturer’s instructions. Afterward, some time was taken to ensure stable measurements. Participants were then asked to vigorously knead a stress ball. As the curve variance is already expected to be high, and oxygenation changes from the baseline occur delayed in submaximal exercise [20,29], time was counted from the first changes from the baseline. After 60 s of the first oxygenation changes from the baseline, the participant was asked to suddenly stop and remain relaxed. Oxygenation changes continued to be measured for 2 min after the exercise.
The resulting oxygenation curves recorded the rSO2 and the changes from the baseline of hHbi, O2Hbi, and cHbi during the light exercise and early recovery. From the resulting oxygenation curves, the area under the curve, the maximum increase overall, the maximum decrease overall, and the time elapsed until the maximum increase or decrease were extracted and included in multivariate analysis (see below).

2.3. Statistical Analysis

In the dataset, the time at which the maximum baseline-adjusted hHbi value occurred during exercise was identified. These per-subject peak times were then modeled using linear regression, with the experimental group, age, and gender entered as covariates. Model summaries were generated to assess overall group effects, and estimated marginal means (LS means) for each group were computed and compared pairwise. Group differences in peak timing were visualized using boxplots, and the LS means (with standard errors and confidence intervals) were displayed as bar graphs. LS means (or least-squares means) are the mod-el-predicted average responses for each factor level, adjusted for the other covariates. They represent what the group means would be if all groups had identical distributions of age and gender, allowing fair comparison even in unbalanced designs.
A similar procedure was applied to the absolute peak heights of the baseline-adjusted hHbi values. A Gaussian family generalized linear model was fitted with the same covariates. Estimated marginal means for peak height by group were extracted and visualized with error bars to illustrate adjusted differences in maximum response magnitude.
To examine the full-time course of hHbi, the normality of residuals was first assessed at each time point using Shapiro–Wilk tests.
To analyze how hHbi, cHbi, and O2Hbi evolved over time and to compare patterns between the two groups, we utilized a generalized additive model (GAM). Unlike standard linear models, GAMs provide the flexibility to model complex, non-linear relationships between predictors and the outcome, making them highly effective for uncovering subtle or irregular trends over time.
We focused on the change from the baseline as our outcome measure, fitting separate smooth functions for each group to track their progress throughout the observation period. This strategy enabled us to identify and contrast the distinctive patterns of change exhibited by each group. Each model included a smooth function of time stratified by group, along with group, age (or standardized age), and gender as parametric terms, and was estimated under a Gaussian family with restricted maximum likelihood. Model diagnostics and summaries were inspected, and the fitted smooths were plotted to illustrate group-specific trajectories.
For a clearer interpretation, we produced graphical representations of each group’s smoothed outcome trajectory, complete with 95% confidence intervals to reflect the uncertainty around the estimates. Additionally, we calculated the pointwise difference between the groups’ smoothed curves. Regions where the interval did not include zero were flagged (marked these intervals in red on the plot) as indicating statistically significant divergence between groups. The difference curve, overlaid with a shaded ribbon indicating significant intervals, provided a clear depiction of the times at which the groups’ hHbi responses departed significantly from one another.
To examine the associations between two sets of variables, a canonical correlation analysis (CCA) was conducted. The first block, labeled as self-reported fatigue variables (Canadian Criteria for ME/CFS yes/no, increased fatigue self-assessment yes/no, Bell score, Chalder fatigue scale, FACIT fatigue scale), and the second block, labeled as measurement variables (including for each variable (rSO2, cHbi, O2Hbi and hHbi) the positive and negative areas under the curve, maximum and minimum measurement, the time of these respective measurements and the overall range), were used for the analysis. All variables were first checked for proper formatting and converted to numeric if necessary. Observations with missing values in either block were removed via complete-case analysis. Next, both blocks were standardized to ensure comparability by centering (mean = 0) and scaling (standard deviation = 1). To visualize the results of the canonical correlation analysis, we plotted the subject scores and variable loadings for each block in a common 2D space. First, we determined shared axis limits by combining the CCA1/CCA2 scores and scaled loadings from both the physiological-measurement and self-report blocks. Finally, we extracted the first canonical variate’s loadings for each block and displayed them as horizontal bar plots, ordering the variables by loading magnitude.
All B_delta_cHbi time series were first plotted to display individual trajectories and overlaid with the group mean curve accompanied by a pointwise 95% confidence band; the median trajectory was also inspected for comparison. The overall time window (0–238 s) was then divided into three a priori segments based on the direction change in the mean curve pattern (0–100 s, 100–150 s, and 150–238 s), and for each subject, a separate linear regression of B_delta_cHbi on time was fitted within each segment as well as across the full curve. These per-subject slopes—both stage-wise and full curve—were compared between control and PCS using Welch’s two-sample t-tests. All analyses and plots were produced in RStudio (version 2023.09.1 Build 494, ©2009–2023 Posit Software, PBC) using stats and base graphics functions. The following packages were applied: for data rearrangement and extraction: Tidyverse package [30], particularly dplyr; for visualization of graphs: ggplot2 [30] and patchwork [31]; mcgv [32] was used for GAM and GLM modeling; for LS means calculation and comparison of groups after GAM and GLM modeling: emmeans package [33]; and for CCA, vegan [34] and ggvegan [35] packages were used.

3. Results

3.1. Demographics and Self-Reported Fatigue

The mean age of the PCS group was 44.26 ± 12.55, and 55% were female. The mean age of the control group was 42.64 ± 16.93, with 54% female. Of the 100 patients with PCS, 82% reported suffering from subjective fatigue symptoms on binary screening, and 83% met the Canadian Criteria for ME/CFS. Time since initial positive COVID-19 -PCR averaged 964 ± 275 days in the PCS cohort. Three self-report questionnaires quantifying CF and its impact on daily life were given to all patients, whether they fulfilled the above questions or not. The Bell score, which categorizes activity and activity-associated symptom severity, is scaled from 100 for those fully active without fatigue to 0 for those bedbound by severe symptoms and requiring assistance in all tasks of daily life. Our PCS cohort scored a median of 30 (95% CI 30–40), categorized as suffering from moderate to severe symptoms most of the time but capable of doing about 2 h of activity a day, including tasks that require leaving the house several times a week. The controls had a median Bell score of 100 (95% CI 100–100). FACIT fatigue score is also counter-proportional to fatigue severity, with a high score of 52 for high activity and no subjective tiredness. The mean PCS FACIT score was 20.38 (SD 10.1), while the mean score of the controls was 47.84 (SD 5.05). The Chalder fatigue scale scores are proportional to fatigue severity, with a high score of 11. PCS scored a mean score of 9.964 (SD 2.038), while controls scored a mean of 0.618 (SD 1.670). Demographics and the contrast of fatigue scores are summarized in Table 1.

3.2. Oxygenation Changes

Muscle oxygenation (rSO2, cHBi, O2Hbi, and hHbi) traces were generated for each participant over the exercise-plus-recovery period. Figure 1 shows a representative deoxygenation–reoxygenation curve from a PCS subject, but there was a high variance in curve amplitude and shape across both groups.
The timing and height of the deoxygenation peak during exercise (hHbiex), which can indicate oxygen extraction efficiency, were analyzed. The highest point of each deoxygenation curve was found along with its respective time point per subject. A Gaussian family generalized linear model was used to calculate differences while age and sex were set as covariates, and the least square (LS) means for sex and group were calculated. PCS patients had earlier but lower hHbi peaks during exercise (p = 0.0015, p = 0.0002, respectively; Table 2, Figure 2).
To account for high variability in the data and the absence of standard normalization references such as maximal effort or incremental exercise, we applied a series of generalized additive models (GAMs) to examine time-based trends across groups (control vs. PCS).
Smoothed curves were fitted separately for each group to visualize changes over time in delta O2Hb, delta cHb, delta HHb, and regional oxygen saturation (rSO2%). These trends are presented in Figure 3. The accompanying difference plots show the estimated difference between group-specific smooths over time, with shaded areas representing 95% confidence intervals. Red shading indicates time intervals where the difference between groups was statistically significant, suggesting divergent physiological responses over time.
This modeling approach reveals group-dependent differences in hemodynamic behavior throughout the observation period, even in the absence of traditional normalization procedures (Figure 3).
CHbi measures the change of total Hb in the investigated tissue. As Mb is localized in the muscle, this is a heavy predictor for hematocrit. Although there is evidence that hematocrit can change somewhat independently of blood flow during exercise, large positive changes in cHbi suggest capillary recruitment and blood flow changes. Therefore, an independent-samples t-test was conducted to compare the overall cHbi-time slopes of patients with PCS and controls (Figure 4). There was a statistically significant difference between both two groups (p = 0.034, [95% CI: –0.0225, –0.00087]). On average, the control group exhibited a steeper full curve slope (M = 0.03324) than the PCS group (M = 0.02153), indicating that, across the entire time series, hematocrit (as reflected by B_delta_cHbi) increased more rapidly in controls than in PCS. This suggests that the condition defining the PCS group is associated with a measurable slowing of the overall response profile and may hint at perfusion differences.

3.3. Multivariate Association Between Self-Reported Fatigue Scores and Masimo-Derived Oxygenation Metrics

Canonical correlation analysis (CCA) was used to uncover the multivariate relationship between five self-report fatigue scales (Canadian Criteria, fatigue symptoms, Bell score, Chalder fatigue, FACIT fatigue) and 28 Masimo-derived oxygenation metrics. The analysis revealed a significant association between the two variable datasets, with the first pair of canonical variates yielding a canonical correlation of rc = 0.71, as determined by permutation testing (p < 0.001). This result indicates a strong latent relationship between subjective fatigue assessments and objective physiological responses. To enhance interpretability, a CCA biplot was generated to visualize the first two canonical dimensions (Figure 5). In this graph, the x-axis and y-axis represent the first and second canonical variates, respectively. Arrows denote the canonical loadings, which correspond to the correlations between the original variables and their associated canonical variates. These are plotted in a shared two-dimensional space to facilitate joint interpretation. Red vectors represent questionnaire-based fatigue scores, while blue vectors represent physiological measures. The distance and direction of each vector from the origin indicate the magnitude and direction of its contribution to the canonical dimensions.

3.3.1. First Canonical Dimension

The first canonical dimension (horizontal axis) biplot explains the largest proportion of the shared variance. On this axis, max_O2HBi (maximum oxygenated Hb), cHBi_posAUC (positive deoxygenated Hb in area under the curve), and CanCrit (Canadian Criteria) have the highest positive loadings, suggesting that individuals with the strong endorsement of Canadian diagnostic fatigue criteria tend to show elevated muscle oxygenation responses. In contrast, negative loadings on this axis, particularly from FatigueSx (self-reported fatigue symptom) and FacitF (FACIT fatigue), imply that individuals reporting higher levels of general fatigue tend to exhibit attenuated oxygenated Hb responses.

3.3.2. Second Canonical Dimension

The second canonical dimension (vertical axis) captures a distinct orthogonal pattern of variation, which appears to reflect temporal and depth-related characteristics of desaturation. It is driven positively by min_rSO2 (minimum tissue oxygen saturation) and t_max_cHBi (time to the highest total Hb change from the baseline) and negatively influenced by ChalderF score (Chalder Fatigue). The second dimension differentiates individuals based on the dynamics of their oxygenation profiles: those with deeper desaturation versus those whose fatigue is more dominantly expressed using the Chalder scale.

3.3.3. Canonical Correlation Analysis Biplot

The biplot quadrants (Figure 5) offer additional insight into the variation across participants. Individuals located in the upper-right quadrant are characterized by high Canadian Criteria scores and prominent oxygenated hemoglobin excursions, suggesting a physiology-linked fatigue phenotype. Conversely, those in the lower-left quadrant report greater general fatigue severity (as indicated by FatigueSx and FacitF) alongside blunted oxygenation responses, revealing two distinct fatigue physiology phenotypes.
Although the biplot enables an intuitive visualization of the joint structure between fatigue and physiological domains, the relevance of each variable is inferred from the relative magnitude and direction of its canonical loading. No explicit threshold was applied; instead, variables represented by vectors farther from the origin are interpreted as exerting greater influence on the corresponding canonical dimension. To complement the biplot, two bar plots were created to provide a clearer depiction of the variable contributions. Figure 6 presents the canonical loadings of the five self-reported fatigue scales on Canonical Variate 1 (CV1), ordered from most negative to most positive, providing a clearer view of each scale’s contribution to the latent dimension. Scales with positive loadings (CanCrit, ChalderF, BellScore) increase as CV1 rises, whereas those with negative loadings (FatigueSx, FacitF) decrease. The length of each bar denotes the magnitude of the Pearson correlation between that scale and CV1, highlighting which questionnaires contribute most strongly to the latent fatigue dimension. The Canadian Criteria scale (CanCrit) loads most strongly in the positive direction, closely followed by the Chalder fatigue scale (ChalderF), indicating that higher scores on these instruments are associated with increases along the primary multivariate axis. The traditional Bell score sits near zero, contributing only marginally, whereas the fatigue symptoms index (FatigueSx) and particularly the FACIT fatigue scale (FacitF) load negatively, signifying that greater self-reported fatigue on those measures corresponds to decreases in the canonical dimension.
Figure 7 provides a complementary view, showing the Masimo physiological measurements’ loadings on CV1, revealing which oxygenation metrics most closely track the fatigue scales. Maximum oxygenated Hb (max_O2HBi) shows the highest positive loading, with its time-to-peak (t_max_O2HBi) and the positive area under the curve for total Hb (cHBi_posAUC) also loading strongly positive. In contrast, variables such as minimum deoxygenated Hb (min_hHBi), its time to minimum (t_min_hHBi), and the range of hHBi (rng_hHBi) load negatively, indicating that deeper or earlier drops in Hb saturation oppose the multivariate pattern defined by the fatigue scales.

4. Discussion

PCS is a post-viral disorder, summarizing several subgroups. One of them is characterized by its clinical major symptom, PEM [3]. It is hypothesized that a restricted microcirculation, accompanied by ischemia-reperfusion, might induce or maintain PEM. Recent data yielded evidence that a subgroup of patients with PCS showed an impaired capillary microcirculation mapped on the retina by OCT-angiography [13,16]. It assumed that a special autoimmune phenomenon characterized by functional autoantibodies targeting G-protein coupled receptors (GPCR-fAAb), accompanied by ischemia, triggers clinical PCS symptoms. This hypothesis was substantiated first by a successful healing attempt with Rovunaptabin (BC007) [17] and, afterward, a clinical phase IIa study [18], showing an improvement of fatigue after neutralization of GPCR-fAAb. As PCS diagnosis lacks objective biomarkers to date, the aim is to establish novel biomarkers for the visualization of oxygenation deficiencies. Thus, the aim was to investigate the (de)oxygenation of patients with PCS compared with controls during and after light exercise.
Analysis of our extensive cohort revealed that even light exercise elicits differences in oxygenation responses and local hematocrit in patients with PCS compared to controls. These differences appeared to become more pronounced during recovery after short exercise and resulted in a lower rSO2 trend by the end of observation in PCS. Some of these differences, most strongly the peak of O2Hbi, were associated with self-reported fatigue questionnaires, further supporting the link between fatigue and oxygenation deficiencies and mitochondrial and endothelial dysfunction.
NIRS is clinically used to assess oxygenation in patients in intensive care or during cardiac surgeries, as it non-invasively and continuously measures the oxygenation state of hemoglobin within tissues and the regional oxygen saturation [36,37]. In devices that support two detectors per sensor, deep tissues can be selectively monitored according to the modified Lambert–Beer Law. Thus, the depth of investigation is tied to the detector spacing, which can lead to difficulty in assessing patients with very low or very high BMI [19]. Correct sensor placement and secure adherence are necessary for stable measurements. Furthermore, the absorption spectra of Hb and Mb overlap, so the variables reflect the oxygenation state of both. In healthy individuals, however, Mb oxygenation is assumed to remain at the same levels during exercise, so changes from the baseline oxygenation are expected to reflect only hemoglobin oxygenation [19]. The most studied variable in literature is rSO2, as only newer generation devices can differentiate between changes in O2Hb, hHb, and cHb [38].
Previous investigations used incremental or maximal exercise [29,39], fractions of the maximum voluntary contractions [40], or vascular occlusion [7] to measure muscle oxygen consumption. Implementation of light exercise avoids triggering PEM. As the clinical need for diagnosis and follow-up of patients with PCS and PEM is high and PEM worsens abnormal muscle findings [4], implementation of a protocol, which even wheelchair-bound PCS patients were able to follow, would be recommended.
In healthy individuals, during exercise, rSO2 decreases as an acute response to heavy exercise. At high aerobic exercise rates, microvascular blood flow plateaus and dissociates from arterial blood flow; in addition, the muscle oxygen extraction exponentially decreases after sudden cessation of the exercise [20]. At rest, fractional O2 extraction is said to be ~25% and increases to ~75% during maximal exercise [20].
HHb increases sharply at the start of exercise and can be used as a semiquantitative estimation of the difference between oxygen concentration in arteries and veins [20]. This overshoot is increased in chronic heart failure and peripheral artery disease, leading to impaired O2 diffusion due to decreased microvascular oxygen partial pressure [41]. In myopathies like mitochondrial myopathy or McArdle disease, this hHb overshoot and hHb max are reduced, suggesting excess blood flow for the same work rate, key pathological mechanisms of these diseases [42]. In the present cohort of patients with PCS and PEM, a decreased hHbi max was observed, suggesting impaired muscle oxygen extraction (Figure 2). It could be hypothesized that this might be due to endothelial or mitochondrial dysfunction.
Muscle oxygen extraction follows an exponential decrease during recovery after exercise. This reoxygenation has been postulated to be a tool for the evaluation of functional oxidative performance, as it correlates well with creatine phosphate recovery, a molecule classically used in physiology for the evaluation of skeletal muscle oxidative metabolism [43]. This exponential increase of O2Hbi is likely reflected in our data as a trend. In controls, this steepness was greater in the O2Hbi curve, and the amplitude at the end of observation was higher, potentially suggesting impaired oxidative metabolism during recovery within the PCS cohort. Slowed reoxygenation kinetics but no oxygenation differences during exercise have also been observed in Friedreich’s ataxia [44] and Fibromyalgia [45]. Friedreich’s ataxia is a genetic disease characterized by mitochondrial damage with early symptoms of fatigue, spasticity, and muscle weakness. Fibromyalgia is characterized by increased muscle pain, fatigue, decreased exercise tolerance, loss of concentration, and small fiber neuropathy. These findings were also observed in our patients with PCS, further suggesting a link between impaired reoxygenation and PEM [4].
The multifaceted nature of self-reported fatigue is challenging as there is a lack of objective diagnostic tools for visualization and quantification. Fatigue is reported to be involved in diverse disorders (e.g., cancer) with known and partially unknown pathology. PEM, as one feature of fatigue, is typically characterized by delayed fatigue and characterizes a subgroup of patients with PCS and ME/CFS.
In addition, mental fatigue is one symptom of ‘brain fog’, which is associated with immune-mediated disorders (e.g., systemic lupus erythematosus [46]). Considering this aspect, functional NIRS (fNIRS) could potentially be a viable option to measure mental fatigue in patients with PCS. The use of fNIRS to measure fatigue has been reviewed by Yan et al. [47]. Previously, most studies measured changes from the baseline during fatiguing tasks. As PCS patients complain of chronic brain fog and are likely to have perfusion alterations, it is unclear if simply measuring changes from the baseline would yield results. Currently, most fNIRS devices are custom-built and incorporate EEG. EEG and the use of a frequency domain NIRS emitter, capable of detecting the absolute tissue concentration of hemoglobin, would help find a potential baseline and differences as well.
A previous study investigating muscle tissue oxygenation of the vastus lateralis in patients with PCS was previously performed, but it did not show significance compared to controls [48]. Yet, the cohort size was lower (36 PCS, 11 controls), and measurements were conducted every 30 s during standing and walking (6 min walking test) and after exercise [48].
In addition, previous data offer that quantification of tissue oxygenation might be best reflected in the slopes of the oxygenation curves after vascular occlusion [7].
Interindividual variability is known to be high in NIRS measurements, largely due to two factors: the limitation in applying the modified Lambert–Beer law is that each individual’s optical scatter value is not known and is likely subject to alteration with changes in blood flow. Further on, the relative contribution of arterial, venous, and capillary hemoglobin to the measurement depends on the placement of the sensor on the individual and reactive hyperemia during exercise [19].
In response to exercise perfusion, the total Hb concentration of the affected area is increased, which is associated with an increase in total Hb (i.e., cHbi). Local hematocrit can even change independently of blood flow during exercise, which is a phenomenon that is not fully elucidated. As the data of the present study showed an increase of cHbi in controls compared to patients with PCS, this could potentially reflect a slower capillary recruitment. It can be hypothesized that this might be a consequence of microclot load, altered physical blood cell characteristics, or endothelial dysfunction. Consequently, the impaired oxygen uptake of the muscles might be mediated by defects in the cellular respiration of skeletal muscle, reduced diffusion across the vascular wall, or a combination of these factors.
In summary, the data of the present study show that NIRS might be a potentially viable tool to assess vascular dysregulation after exertion in patients with PCS. Further clinical studies are necessary, investigating different light exercise durations and their long-term recovery effects.

5. Conclusions

PCS is a challenging disorder, as the diagnosis lacks objective biomarkers up to date. As the data of the present study offered that the subgroup of patients with PCS and PEM showed impaired deoxygenation after light exercise, these data support the hypothesis of ischemia as a pathogenetic factor in PEM. Visualization and quantification of this restricted deoxygenation might offer a diagnostic tool in this subgroup of patients with PCS, showing PEM as a major clinical symptom. In addition, this test setup might be useful for bedbound patients.

Author Contributions

Conceptualization, B.H., A.W., C.Y.M., M.G., J.R. and A.B.; methodology, A.W., A.-M.L. and M.L.; validation, M.L., A.-M.L. and B.H.; formal analysis, M.L. and A.-M.L.; investigation, M.I., H.S., M.J., L.B., T.K. and J.R.; resources, B.H., A.W. and M.L.; data curation, A.-M.L. and M.L.; writing—original draft preparation, A.-M.L. and M.L.; writing—review and editing, B.H., M.G. and A.W.; visualization, A.-M.L. and M.L.; supervision, B.H., M.G., C.Y.M. and J.R.; project administration, B.H.; funding acquisition, B.H. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the Bavarian State Ministry of Health, Care and Prevention (StMGP, disCOVer 2.0, Gesamt-2490-PCS-2023), the German Federal Ministry of Education and Research (BMBF, 01EO2105, iIMMUNE_ACS), and the German Research Foundation (DFG, 401821119/GRK2504).

Institutional Review Board Statement

The study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Ethics Committee of the Medical Faculty of Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) (no: 295-20-B, 20 Febuary 2024).

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

The datasets generated and/or analyzed during the current study are available from the corresponding author, B.H., on reasonable request.

Conflicts of Interest

The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.

Abbreviations

The following abbreviations are used in this manuscript:
PCSPost-COVID-Syndrome
PEMPost-exertional malaise
NIRSNear-infrared regional spectroscopy
LCLong COVID
CFChronic fatigue
GPCR-fAAbFunctional autoantibodies targeting G-protein coupled receptors
HbHemoglobin
MbMyoglobin
PCRPolymerase chain reaction
ME/CFSMyalgic Encephalomyelitis/Chronic Fatigue Syndrome
LFTLung function test
LVEFLeft ventricular ejection fraction
Delta O2HbiChange in oxygenated hemoglobin/myoglobin
Delta hHbiChange in deoxygenated hemoglobin/myoglobin
Delta cHbiTotal change in hemoglobin/myoglobin
rSO2Regional oxygen saturation
GAMGeneralized additive model
CCACanonical Correlation Analysis
AUCArea under the curves
rSO2_posAUCPositive area under the curve of regional oxygen saturation
rSO2_negAUCNegative area under the curve of regional oxygen saturation
t_min_rSO2Time to minimum rSO2 during observation
t_max_rSO2Time to maximum rSO2 during observation
max_rSO2Maximum rSO2 value during observation
min_rSO2Minimum rSO2 value during observation
Rng_rSO2Range of rSO2 values across all time points
cHbi_posAUCPositive area under the curve of total change in cHbi
cHbi_negAUCNegative area under the curve of total change in cHbi
t_min_cHbiTime to minimum cHbi during observation
t_max_cHbiTime to maximum cHbi during observation
max_cHbiMaximum cHbi value during observation
min_cHbiMinimum cHbi value during observation
rng_cHbiRange of cHbi values across all time points
O2Hbi_posAUCPositive area under the curve of total change in O2Hbi
O2Hbi_negAUCNegative area under the curve of total change in O2Hbi
t_min_O2HbiTime to minimum O2Hbi during observation
t_max_O2HbiTime to maximum O2Hbi during observation
max_O2HbiMaximum O2Hbi value during observation
min_O2HbiMinimum O2Hbi value during observation
rng_O2HbiRange of O2Hbi values across all time points
hHbi_posAUCPositive area under the curve of total change in hHbi
hHbi_negAUCNegative area under the curve of total change in hHbi
t_min_hHbiTime to minimum hHbi during observation
t_max_hHbiTime to maximum hHbi during observation
max_hHbiMaximum hHbi value during observation
min_hHbiMinimum hHbi value during observation
rng_hHbiRange of hHbi values across all time points
hHbiexDeoxygenated hemo/myoglobin during exercise
LS meansLeast square means
CV1Canonical variate 1
CanCritCanadian Criteria for ME/CFS
FacitFFACIT fatigue score
FatigueSxSelf-reported fatigue symptom
ChalderFChalder fatigue scale
fNIRSFunctional near-infrared regional spectroscopy

References

  1. WHO. WHO-Post COVID-19 Condition (Long COVID). 26 February 2025. Available online: https://www.who.int/news-room/fact-sheets/detail/post-covid-19-condition-(long-covid) (accessed on 28 February 2025).
  2. World Health Organization Post COVID-19 Condition (Long COVID). 7 December 2022. Available online: https://www.who.int/europe/news-room/fact-sheets/item/post-covid-19-condition (accessed on 28 February 2025).
  3. Davis, H.E.; Assaf, G.S.; McCorkell, L.; Wei, H.; Low, R.J.; Re’em, Y.; Redfield, S.; Austin, J.P.; Akrami, A. Characterizing Long COVID in an International Cohort: 7 Months of Symptoms and Their Impact. eClinicalMedicine 2021, 38, 101019. [Google Scholar] [CrossRef]
  4. Appelman, B.; Charlton, B.T.; Goulding, R.P.; Kerkhoff, T.J.; Breedveld, E.A.; Noort, W.; Offringa, C.; Bloemers, F.W.; van Weeghel, M.; Schomakers, B.V.; et al. Muscle Abnormalities Worsen after Post-Exertional Malaise in Long COVID. Nat. Commun. 2024, 15, 17. [Google Scholar] [CrossRef]
  5. Premraj, L.; Kannapadi, N.V.; Briggs, J.; Seal, S.M.; Battaglini, D.; Fanning, J.; Suen, J.; Robba, C.; Fraser, J.; Cho, S.-M. Mid and Long-Term Neurological and Neuropsychiatric Manifestations of Post-COVID-19 Syndrome: A Meta-Analysis. J. Neurol. Sci. 2022, 434, 120162. [Google Scholar] [CrossRef]
  6. Lechuga, G.C.; Morel, C.M.; De-Simone, S.G. Hematological Alterations Associated with Long COVID-19. Front. Physiol. 2023, 14, 1203472. [Google Scholar] [CrossRef]
  7. Schäfer, H.; Teschler, M.; Mooren, F.C.; Schmitz, B. Altered Tissue Oxygenation in Patients with Post COVID-19 Syndrome. Microvasc. Res. 2023, 148, 104551. [Google Scholar] [CrossRef]
  8. Davis, H.E.; McCorkell, L.; Vogel, J.M.; Topol, E.J. Long COVID: Major Findings, Mechanisms and Recommendations. Nat. Rev. Microbiol. 2023, 21, 133–146. [Google Scholar] [CrossRef]
  9. Kubánková, M.; Hohberger, B.; Hoffmanns, J.; Fürst, J.; Herrmann, M.; Guck, J.; Kräter, M. Physical Phenotype of Blood Cells Is Altered in COVID-19. Biophys. J. 2021, 120, 2838–2847. [Google Scholar] [CrossRef]
  10. Kell, D.B.; Laubscher, G.J.; Pretorius, E. A Central Role for Amyloid Fibrin Microclots in Long COVID/PASC: Origins and Therapeutic Implications. Biochem. J. 2022, 479, 537–559. [Google Scholar] [CrossRef]
  11. Wallukat, G.; Hohberger, B.; Wenzel, K.; Fürst, J.; Schulze-Rothe, S.; Wallukat, A.; Hönicke, A.S.; Müller, J. Functional Autoantibodies against G-Protein Coupled Receptors in Patients with Persistent Long-COVID-19 Symptoms. J. Transl. Autoimmun. 2021, 4, 100100. [Google Scholar] [CrossRef]
  12. Proal, A.D.; VanElzakker, M.B.; Aleman, S.; Bach, K.; Boribong, B.P.; Buggert, M.; Cherry, S.; Chertow, D.S.; Davies, H.E.; Dupont, C.L.; et al. SARS-CoV-2 Reservoir in Post-Acute Sequelae of COVID-19 (PASC). Nat. Immunol. 2023, 24, 1616–1627. [Google Scholar] [CrossRef]
  13. Schlick, S.; Lucio, M.; Wallukat, G.; Bartsch, A.; Skornia, A.; Hoffmanns, J.; Szewczykowski, C.; Schröder, T.; Raith, F.; Rogge, L.; et al. Post-COVID-19 Syndrome: Retinal Microcirculation as a Potential Marker for Chronic Fatigue. Int. J. Mol. Sci. 2022, 23, 13683. [Google Scholar] [CrossRef]
  14. Nägele, M.P.; Haubner, B.; Tanner, F.C.; Ruschitzka, F.; Flammer, A.J. Endothelial Dysfunction in COVID-19: Current Findings and Therapeutic Implications. Atherosclerosis 2020, 314, 58–62. [Google Scholar] [CrossRef]
  15. Wirth, K.J.; Löhn, M. Microvascular Capillary and Precapillary Cardiovascular Disturbances Strongly Interact to Severely Affect Tissue Perfusion and Mitochondrial Function in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Evolving from the Post COVID-19 Syndrome. Medicina 2024, 60, 194. [Google Scholar] [CrossRef]
  16. Szewczykowski, C.; Mardin, C.; Lucio, M.; Wallukat, G.; Hoffmanns, J.; Schröder, T.; Raith, F.; Rogge, L.; Heltmann, F.; Moritz, M.; et al. Long COVID: Association of Functional Autoantibodies against G-Protein-Coupled Receptors with an Impaired Retinal Microcirculation. Int. J. Mol. Sci. 2022, 23, 7209. [Google Scholar] [CrossRef]
  17. Hohberger, B.; Harrer, T.; Mardin, C.; Kruse, F.; Hoffmanns, J.; Rogge, L.; Heltmann, F.; Moritz, M.; Szewczykowski, C.; Schottenhamml, J.; et al. Case Report: Neutralization of Autoantibodies Targeting G-Protein-Coupled Receptors Improves Capillary Impairment and Fatigue Symptoms After COVID-19 Infection. Front. Med. 2021, 8, 1–7. [Google Scholar] [CrossRef]
  18. Hohberger, B.; Ganslmayer, M.; Harrer, T.; Kruse, F.; Maas, S.; Borst, T.; Heimke-Brinck, R.; Stog, A.; Knauer, T.; Rühl, E.; et al. Safety, Tolerability and Clinical Effects of BC007 (Rovunaptabin) on Fatigue and Quality of Life in Patients with Post-COVID Syndrome (ReCOVer): A Prospective, Exploratory, Randomised, Placebo-Controlled, Double-Blind, Crossover Phase IIa Clinical Trial. medRxiv 2024. [Google Scholar] [CrossRef]
  19. Barstow, T.J. Understanding near Infrared Spectroscopy and Its Application to Skeletal Muscle Research. Rev. Cores Reprod. Physiol. J. Appl. Physiol. 2019, 126, 1360–1376. [Google Scholar] [CrossRef]
  20. Grassi, B.; Quaresima, V. Near-Infrared Spectroscopy and Skeletal Muscle Oxidative Function in Vivo in Health and Disease: A Review from an Exercise Physiology Perspective. J. Biomed. Opt. 2016, 21, 091313. [Google Scholar] [CrossRef]
  21. Durstenfeld, M.S.; Sun, K.; Tahir, P.; Peluso, M.J.; Deeks, S.G.; Aras, M.A.; Grandis, D.J.; Long, C.S.; Beatty, A.; Hsue, P.Y. Use of Cardiopulmonary Exercise Testing to Evaluate Long COVID-19 Symptoms in Adults: A Systematic Review and Meta-Analysis. JAMA Netw. Open 2022, 5, E2236057. [Google Scholar] [CrossRef]
  22. Carruthers, B.M.; van de Sande, M.I.; De Meirleir, K.L.; Klimas, N.G.; Broderick, G.; Mitchell, T.; Staines, D.; Powles, A.C.P.; Speight, N.; Vallings, R.; et al. Myalgic Encephalomyelitis: International Consensus Criteria. J. Intern. Med. 2011, 270, 327–338. [Google Scholar] [CrossRef]
  23. Jackson, C. The Chalder Fatigue Scale (CFQ 11). Occup. Med. 2015, 65, 86. [Google Scholar] [CrossRef]
  24. Bell, D.S. The Doctor’s Guide to Chronic Fatigue Syndrome: Understanding, Treating, and Living with CFIDS; Addison-Wesley Publishing Company: Reading, MA, USA, 1995; ISBN 978-0201407976. [Google Scholar]
  25. Webster, K.; Cella, D.; Yost, K. The Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System: Properties, Applications, and Interpretation. Health Qual. Life Outcomes 2003, 1, 79. [Google Scholar] [CrossRef]
  26. Baum, P.; Do, L.; Deterding, L.; Lier, J.; Kunis, I.; Saur, D.; Classen, J.; Wirtz, H.; Laufs, U. Cardiac Function in Relation to Functional Status and Fatigue in Patients with Post-COVID Syndrome. Sci. Rep. 2022, 12, 19575. [Google Scholar] [CrossRef]
  27. Thiele, K.; Balfanz, P.; Müller, T.; Hartmann, B.; Spiesshoefer, J.; Grebe, J.; Müller-Wieland, D.; Marx, N.; Dreher, M.; Daher, A. Cardiopulmonary Work up of Patients with and without Fatigue 6 Months after COVID-19. Sci. Rep. 2022, 12, 18038. [Google Scholar] [CrossRef]
  28. Mancini, D.M.; Bolinger, L.; Li, H.; Kendrick, K.; Chance, B.; Wilson, J.R. Validation of Near-Infrared Spectroscopy in Humans. J. Appl. Physiol. 1994, 77, 2740–2747. [Google Scholar] [CrossRef]
  29. Ferreira, L.F.; Koga, S.; Barstow, T.J. Dynamics of Noninvasively Estimated Microvascular O2 Extraction during Ramp Exercise. J. Appl. Physiol. 2007, 103, 1999–2004. [Google Scholar] [CrossRef]
  30. Wickham, H.; Averick, M.; Bryan, J.; Chang, W.; McGowan, L.; François, R.; Grolemund, G.; Hayes, A.; Henry, L.; Hester, J.; et al. Welcome to the Tidyverse. J. Open Source Softw. 2019, 4, 1686. [Google Scholar] [CrossRef]
  31. Pedersen, T.L. Patchwork: The Composer of Plots; R Package Version 1.1.3; 2022. Available online: https://CRAN.R-project.org/package=patchwork (accessed on 27 May 2025).
  32. Wood, S.N. Fast Stable Restricted Maximum Likelihood and Marginal Likelihood Estimation of Semiparametric Generalized Linear Models. J. R. Stat. Soc. Ser. B Stat. Methodol. 2011, 73, 3–36. [Google Scholar] [CrossRef]
  33. Russell, L. Emmeans: Estimated Marginal Means, Aka Least-Squares Means; R Package Version 1.10.1; 2024. Available online: https://CRAN.R-project.org/package=emmeans (accessed on 27 May 2025).
  34. Oksanen, J.; Blanchet, F.G.; Friendly, M.; Kindt, R.; Legendre, P.; McGlinn, D.; Minchin, P.R.; O’Hara, R.B.; Simpson, G.L.; Solymos, P.; et al. Vegan: Community Ecology Package; R Package Version 2.5-7.E; 2020. Available online: https://CRAN.R-project.org/package=vegan (accessed on 27 May 2025).
  35. Simpson, G.L. Ggvegan: “ggplot2” Plots for the “Vegan” Package; R Package Version 0.1-0; 2019. Available online: https://github.com/gavinsimpson/ggvegan (accessed on 27 May 2025).
  36. Navarro-Perez, R.; Romero-García, N.; Paolessi, C.; Robba, C.; Badenes, R. Cerebral Oximetry in High-Risk Surgical Patients: Where Are We? Curr. Opin. Crit. Care 2024, 30, 672–678. [Google Scholar] [CrossRef]
  37. Saugel, B.; Annecke, T.; Bein, B.; Flick, M.; Goepfert, M.; Gruenewald, M.; Habicher, M.; Jungwirth, B.; Koch, T.; Kouz, K.; et al. Intraoperative Haemodynamic Monitoring and Management of Adults Having Non-Cardiac Surgery: Guidelines of the German Society of Anaesthesiology and Intensive Care Medicine in Collaboration with the German Association of the Scientific Medical Societies. J. Clin. Monit. Comput. 2024, 38, 945–959. [Google Scholar] [CrossRef]
  38. Perrey, S.; Quaresima, V.; Ferrari, M. Muscle Oximetry in Sports Science: An Updated Systematic Review. Sports Med. 2024, 54, 975–996. [Google Scholar] [CrossRef]
  39. Hammer, S.M.; Alexander, A.M.; Didier, K.D.; Smith, J.R.; Caldwell, J.T.; Sutterfield, S.L.; Ade, C.J.; Barstow, T.J. The Noninvasive Simultaneous Measurement of Tissue Oxygenation and Microvascular Hemodynamics during Incremental Handgrip Exercise. J. Appl. Physiol. 2018, 124, 604–614. [Google Scholar] [CrossRef]
  40. Lucero, A.A.; Addae, G.; Lawrence, W.; Neway, B.; Credeur, D.P.; Faulkner, J.; Rowlands, D.; Stoner, L. Reliability of Muscle Blood Flow and Oxygen Consumption Response from Exercise Using Near-infrared Spectroscopy. Exp. Physiol. 2018, 103, 90–100. [Google Scholar] [CrossRef]
  41. Sperandio, P.A.; Oliveira, M.F.; Rodrigues, M.K.; Berton, D.C.; Treptow, E.; Nery, L.E.; Almeida, D.R.; Neder, J.A. Sildenafil Improves Microvascular O2 Delivery-to-Utilization Matching and Accelerates Exercise O2 Uptake Kinetics in Chronic Heart Failure. Am. J. Physiol. Heart Circ. Physiol. 2012, 303, H1474–H1480. [Google Scholar] [CrossRef]
  42. Grassi, B.; Marzorati, M.; Lanfranconi, F.; Ferri, A.; Longaretti, M.; Stucchi, A.; Vago, P.; Marconi, C.; Morandi, L. Impaired Oxygen Extraction in Metabolic Myopathies: Detection and Quantification by Near-infrared Spectroscopy. Muscle Nerve 2007, 35, 510–520. [Google Scholar] [CrossRef]
  43. Mccully, K.K.; Smith, S.; Rajaei, S.; Leigh, J.S.; Natelson, B.H.; Mccully, K.K.; Center, R. Muscle Metabolism with Blood FLow Restriction in Chronic Fatigue Syndrome. J. Appl. Physiol. 2004, 96, 871–878. [Google Scholar] [CrossRef]
  44. Lynch, D.R.; Lech, G.; Farmer, J.M.; Balcer, L.J.; Bank, W.; Chance, B.; Wilson, R.B. Near Infrared Muscle Spectroscopy in Patients with Friedreich’s Ataxia. Muscle Nerve 2002, 25, 664–673. [Google Scholar] [CrossRef]
  45. Shang, Y.; Gurley, K.; Symons, B.; Long, D.; Srikuea, R.; Crofford, L.J.; Peterson, C.A.; Yu, G. Noninvasive Optical Characterization of Muscle Blood Flow, Oxygenation, and Metabolism in Women with Fibromyalgia. Arthritis Res. Ther. 2012, 14, R236. [Google Scholar] [CrossRef]
  46. Barraclough, M.; McKie, S.; Parker, B.; Jackson, A.; Pemberton, P.; Elliott, R.; Bruce, I.N. Altered Cognitive Function in Systemic Lupus Erythematosus and Associations with Inflammation and Functional and Structural Brain Changes. Ann. Rheum. Dis. 2019, 78, 934–940. [Google Scholar] [CrossRef]
  47. Yan, Y.; Guo, Y.; Zhou, D. Mental Fatigue Causes Significant Activation of the Prefrontal Cortex: A Systematic Review and Meta-analysis of FNIRS Studies. Psychophysiology 2025, 62, e14747. [Google Scholar] [CrossRef]
  48. Nascimento, E.P.d.; Nascimento, L.F.E.d.; Castro, L.d.F.; de Barros, V.C.d.; Bandeira, E.R.P.; Wanderley e Lima, T.B.; Otto-Yáñez, M.; Fregonezi, G.A.d.F.; Resqueti, V.R. Cardiac Hemodynamics, Tissue Oxygenation, and Functional Capacity in Post-COVID-19 Patients. Medicina 2025, 61, 124. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Exemplary output curve of an individual with PCS. There was unfavorable high individual variance in amplitude and curve morphology.
Figure 1. Exemplary output curve of an individual with PCS. There was unfavorable high individual variance in amplitude and curve morphology.
Biomedicines 13 01371 g001
Figure 2. Changes in deoxygenation during exercise. (a) The timing of the peak in hHbiex during the period of exercise. Patients with PCS had significantly earlier peaks (LS means 31.6 s ± 0.416. df 4496, Cl 30.8 to 32.4) compared to controls (LS means 33.9 s ± 0.588 df 4496, Cl 32.7 to 35.0), p = 0.0015 (**). (b) Peak deoxygenation values during exercise were significantly lower in PCS patients (LS means 2.19 ± 0.0506, df 4496, Cl 2.09 to 2.28), than in controls (LS means 2.51 ± 0.0714, 4496, Cl 2.37 to 2.65), p = 0.0002 (**). (c) Generalized additive model (GAM) illustrating the trends of change in hHbi during exercise per group. In the top left shows the difference in value as pairwise comparisons of these GAM trend values per time point. The shaded confidence intervals are colored red, where pairwise comparisons yielded a significant difference.
Figure 2. Changes in deoxygenation during exercise. (a) The timing of the peak in hHbiex during the period of exercise. Patients with PCS had significantly earlier peaks (LS means 31.6 s ± 0.416. df 4496, Cl 30.8 to 32.4) compared to controls (LS means 33.9 s ± 0.588 df 4496, Cl 32.7 to 35.0), p = 0.0015 (**). (b) Peak deoxygenation values during exercise were significantly lower in PCS patients (LS means 2.19 ± 0.0506, df 4496, Cl 2.09 to 2.28), than in controls (LS means 2.51 ± 0.0714, 4496, Cl 2.37 to 2.65), p = 0.0002 (**). (c) Generalized additive model (GAM) illustrating the trends of change in hHbi during exercise per group. In the top left shows the difference in value as pairwise comparisons of these GAM trend values per time point. The shaded confidence intervals are colored red, where pairwise comparisons yielded a significant difference.
Biomedicines 13 01371 g002
Figure 3. GAM of the overall curves of hHbi, O2Hbi, cHbi, and rSO2, respectively: (a,c,e,g) Change from the baseline plotted over time for each group. (b,d,f,h) Graphed difference between the two curves. The shaded area shows the 95% confidence interval and is colored red where there is a significant difference.
Figure 3. GAM of the overall curves of hHbi, O2Hbi, cHbi, and rSO2, respectively: (a,c,e,g) Change from the baseline plotted over time for each group. (b,d,f,h) Graphed difference between the two curves. The shaded area shows the 95% confidence interval and is colored red where there is a significant difference.
Biomedicines 13 01371 g003aBiomedicines 13 01371 g003b
Figure 4. Curves for slope calculation: The mean and median curves of cHbi with 95% CI are shown per group, gray curves show individuals (a); Average curves (mean of each group per time point of cHbi) are plotted together, and the overall slope was calculated. Controls exhibited a steeper slope on average p = 0.034 (b).
Figure 4. Curves for slope calculation: The mean and median curves of cHbi with 95% CI are shown per group, gray curves show individuals (a); Average curves (mean of each group per time point of cHbi) are plotted together, and the overall slope was calculated. Controls exhibited a steeper slope on average p = 0.034 (b).
Biomedicines 13 01371 g004
Figure 5. Canonical correlation analysis (CCA) biplot visualizes both (1) the participant scores in the space of the first two canonical variates (CCA1 and CCA2) and (2) the variable loadings (arrows) for each measure. Red points and arrows correspond to the self-reported fatigue scales; blue points and arrows correspond to the oxygenation metrics. Red points show each participant’s CCA1–CCA2 coordinates derived from the five fatigue scale variables, while blue points show the same participants’ coordinates derived from the set of physiological measurements. Red arrows depict how each self-report scale “loads” onto the two canonical axes: arrow length reflects the strength of that variable’s contribution, and arrow direction indicates whether it aligns with CCA1, CCA2, or both. Blue arrows similarly illustrate the loadings of the oxygen measurement variables within the same canonical space; arrows pointing in similar directions are positively correlated, whereas those pointing in roughly opposite directions are negatively correlated.
Figure 5. Canonical correlation analysis (CCA) biplot visualizes both (1) the participant scores in the space of the first two canonical variates (CCA1 and CCA2) and (2) the variable loadings (arrows) for each measure. Red points and arrows correspond to the self-reported fatigue scales; blue points and arrows correspond to the oxygenation metrics. Red points show each participant’s CCA1–CCA2 coordinates derived from the five fatigue scale variables, while blue points show the same participants’ coordinates derived from the set of physiological measurements. Red arrows depict how each self-report scale “loads” onto the two canonical axes: arrow length reflects the strength of that variable’s contribution, and arrow direction indicates whether it aligns with CCA1, CCA2, or both. Blue arrows similarly illustrate the loadings of the oxygen measurement variables within the same canonical space; arrows pointing in similar directions are positively correlated, whereas those pointing in roughly opposite directions are negatively correlated.
Biomedicines 13 01371 g005
Figure 6. Bar plot of the first-variate canonical loadings for the five self-reported fatigue scales. Each bar shows the Pearson correlation between a questionnaire scale and Canonical Variate 1: its length indicates the strength of that scale’s contribution, and its direction (rightwards = positive, leftwards = negative) indicates whether the scale increases or decreases as the canonical score rises.
Figure 6. Bar plot of the first-variate canonical loadings for the five self-reported fatigue scales. Each bar shows the Pearson correlation between a questionnaire scale and Canonical Variate 1: its length indicates the strength of that scale’s contribution, and its direction (rightwards = positive, leftwards = negative) indicates whether the scale increases or decreases as the canonical score rises.
Biomedicines 13 01371 g006
Figure 7. Bar plot of the first-variate canonical loadings for the Masimo physiological measurements. Each bar represents the Pearson correlation between a measurement variable and Canonical Variate 1: its length indicates how strongly that metric contributes to the shared fatigue–physiology dimension and its direction (bars extending right = positive loadings; bars extending left = negative loadings) shows whether the variable rises or falls as the canonical score increases. The variable names are explained in the abbreviations table.
Figure 7. Bar plot of the first-variate canonical loadings for the Masimo physiological measurements. Each bar represents the Pearson correlation between a measurement variable and Canonical Variate 1: its length indicates how strongly that metric contributes to the shared fatigue–physiology dimension and its direction (bars extending right = positive loadings; bars extending left = negative loadings) shows whether the variable rises or falls as the canonical score increases. The variable names are explained in the abbreviations table.
Biomedicines 13 01371 g007
Table 1. Demographic data of participants and questionnaire scores.
Table 1. Demographic data of participants and questionnaire scores.
VariablePCSControl
Age44.28 (19–78; SD 12.55)42.64 (22–68; SD 16.93)
Sex55% female54% female
Time from positive PCR test to investigation (days)909 (126–1565)N/A 1
Canadian Criteria83% fulfillment0% fulfillment
Median Bell score30 (95% CI 30–40)100 (95% CI 100)
FACIT fatigue score20.38 (SD 10.1)47.84 (SD 5.05)
Chalder fatigue scale9.964 (SD 2.038)0.618 (SD 1.670)
1 Control group constituted of people who either never had COVID-19 or who had fully recovered from COVID-19.
Table 2. Estimated coefficients, standard errors, t-values, and p-values from the GLM models of Time point and peak of deoxygenated hemo-and myoglobin baseline change (hHbi) during exercise, as a function of the intercept, PCS group, female sex, and age.
Table 2. Estimated coefficients, standard errors, t-values, and p-values from the GLM models of Time point and peak of deoxygenated hemo-and myoglobin baseline change (hHbi) during exercise, as a function of the intercept, PCS group, female sex, and age.
Variable
Time of Peak
hHbiex
EstimateStd. ErrorT ValuePr(>|t|)
Intercept27.678101.2268022.561<2 × 10−16
Group PCS2.275680.71980−3.1620.00158
Age0.120320.681232.6950.00706
Sex Female1.836080.681232.6950.00706
Peak hHbiex value
Intercept1.831540.1489912.293<2 × 10−16
Group PCS−0.325040.08742−3.7180.000203
Age0.018900.002936.4501.23 × 10−10
Sex Female−0.295060.08273−3.5660.000366
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Ladek, A.-M.; Lucio, M.; Weiß, A.; Knauer, T.; Sarmiento, H.; Ilgner, M.; Jakobi, M.; Barteczko, L.; Ganslmayer, M.; Rech, J.; et al. Deoxygenation Trends and Their Multivariate Association with Self-Reported Fatigue in Post-COVID Syndrome. Biomedicines 2025, 13, 1371. https://doi.org/10.3390/biomedicines13061371

AMA Style

Ladek A-M, Lucio M, Weiß A, Knauer T, Sarmiento H, Ilgner M, Jakobi M, Barteczko L, Ganslmayer M, Rech J, et al. Deoxygenation Trends and Their Multivariate Association with Self-Reported Fatigue in Post-COVID Syndrome. Biomedicines. 2025; 13(6):1371. https://doi.org/10.3390/biomedicines13061371

Chicago/Turabian Style

Ladek, Anja-Maria, Marianna Lucio, Andreas Weiß, Thomas Knauer, Helena Sarmiento, Miriam Ilgner, Marie Jakobi, Laura Barteczko, Marion Ganslmayer, Jürgen Rech, and et al. 2025. "Deoxygenation Trends and Their Multivariate Association with Self-Reported Fatigue in Post-COVID Syndrome" Biomedicines 13, no. 6: 1371. https://doi.org/10.3390/biomedicines13061371

APA Style

Ladek, A.-M., Lucio, M., Weiß, A., Knauer, T., Sarmiento, H., Ilgner, M., Jakobi, M., Barteczko, L., Ganslmayer, M., Rech, J., Bergua, A., Mardin, C. Y., & Hohberger, B. (2025). Deoxygenation Trends and Their Multivariate Association with Self-Reported Fatigue in Post-COVID Syndrome. Biomedicines, 13(6), 1371. https://doi.org/10.3390/biomedicines13061371

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop